Back

Growth Differentiation Factor-15. A new, long-term prognostic biomarker in chronic heart failure with preserved or mid-range ejection fraction

25 May 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Diagnostic Methods Biomarkers HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Ana Belen Mendez Fernandez

University Hospital Vall d'Hebron, Barcelona (Spain)

20 More presentations in this session

Presentation thumbnail
The ratio of fibroblast growth factor 23 to phosphorus as a predictor of cardiovascular death in heart failure patients with reduced ejection fraction.
Professor D. Gruson (Brussels, BE)
Abstract Slides
Presentation thumbnail
Soluble ST2/LVMI correlates with native T1 mapping value in 3T cardiac magnetic resonance in patients with dilated cardiomyopathy
Associate Professor Y. Park (Yangsan, KR)
Abstract
Presentation thumbnail
Dynamics of the stimulating growth factor sST2 and interleukin 33 in acute myocardial infarction
Professor V. Larina (Moscow, RU)
Abstract
Presentation thumbnail
BNP as the biomarker of diagnosis and prognosis in long-term mortality in a cohort with HFpEF and HFrEF in the south of Brazil
Doctor E. Pitthan (Porto Alegre, BR)
Presentation thumbnail
Association between severity of heart failure and chemerin level

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Diagnostic Methods

The Event

Event poster

Heart Failure 2019

25 May - 28 May 2019
You may be interested in
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Session
From genetic signatures to clinical implications
thumbnail
Congress Presentation
Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources